In the immunotherapy-sensitive glioma murine model, M2 macrophages decreased, M1 macrophages increased, CD8 + T-cells increased, the IIS risk score decreased, and the survival was improved after treatment with PD-1 blockade. The gene discussed is CD8A; the disease is glioma.